INHIBITORS OF HEPATITIS C VIRUS

Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed: The compounds are useful in the treatment of Hepatitis C infections.

Saved in:
Bibliographic Details
Main Authors YANG, Zheng-Yu, KARKI, Kapil, Kumar, TRAN, Chinh, Viet, LINK, John, O, ZIPFEL, Sheila, CANALES, Eda, PHILLIPS, Barton, W, ZABLOCKI, Jeff, SANGI, Michael, KATANA, Ashley, Anne, VIVIAN, Randall, W, COTTELL, Jeromy, J, PYUN, Hyung-jung, KATO, Darryl, TAYLOR, James, G, MARTINEZ, Ruben, BJORNSON, Kyla, SIEGEL, Dustin, KOBAYASHI, Tetsuya, SCHRIER, Adam, James, TREJO MARTIN, Teresa, Alejandra
Format Patent
LanguageEnglish
French
German
Published 26.04.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed: The compounds are useful in the treatment of Hepatitis C infections.
Bibliography:Application Number: EP20160190694